Turning Healthcare Failures Into Better Patient Outcomes

Healthcare organizations have long been rewarded for consistency. Clinical protocols, regulatory oversight and quality standards are designed to reduce variation because mistakes can have life-changing consequences. Yet the same structures that protect patients can also discourage experimentation, making it difficult for organizations to improve care delivery, adopt new technologies or rethink outdated processes.

Leading health systems are increasingly recognizing that innovation and patient safety are not opposing goals. Rather, the most successful organizations establish clear guardrails that allow teams to test new ideas in controlled environments, measure outcomes rigorously and scale only what proves effective. Research from the Agency for Healthcare Research and Quality (AHRQ) has consistently shown that organizations with stronger patient safety cultures encourage communication, organizational learning and continuous improvement while reducing preventable harm.

Members of the Senior Executive Healthcare Think Tank bring perspectives spanning clinical medicine, medical technology, digital health, systems engineering, patient experience and healthcare operations. Below, they share how healthcare organizations can move beyond a fear of failure by combining strong governance, data-driven decision-making and structured experimentation to advance innovation while maintaining patient trust.

“The real governance model isn’t ‘take more risk.’ It’s drawing the boundary precisely, then protecting the team’s right to iterate freely inside it.”

– Dorothy Riviere, CEO and Founder of Work Resilience

SHARE IT

Define Clear Boundaries for Innovation

Many healthcare leaders assume that minimizing risk requires minimizing experimentation. Dorothy Riviere, CEO and Founder of Work Resilience, argues that the opposite is often true. In many clinical settings, the safest path to improvement is to clearly define what cannot change while giving frontline teams the freedom to iterate everywhere else.

“Healthcare’s risk aversion makes sense where stakes are life and death. Most of healthcare isn’t that,” she says. “In physical therapy, almost nothing I did was irreversible. The physician’s script set the boundary. Inside it, I had a sandbox. Try a movement pattern. Watch the response. Adjust. Try again.”

She emphasizes that effective governance is not about encouraging more risk-taking, but about drawing precise boundaries around patient safety, testing, observing and adjusting.

“The real governance model isn’t ‘take more risk.’ It’s drawing the boundary precisely, then protecting the team’s right to iterate freely inside it.”

This mindset also translates beyond clinical practice. Riviere notes that she used the same disciplined approach while building a company with a small team, focusing first on identifying the elements that absolutely could not fail while remaining flexible everywhere else.

Physician-Led Governance Keeps Innovation Grounded

For Peter Fotinos, Chief Medical Officer of Excel Medical, innovation succeeds when it is anchored by clinical leadership rather than driven solely by operational or technological priorities. With decades of experience in hormone replacement therapy, preventive medicine and telehealth, Fotinos believes healthcare organizations should treat experimentation as a structured clinical process rather than an open-ended exercise.

“Innovation and patient safety are not competing priorities,” he says.

Rather than asking whether organizations should innovate, leaders should determine how innovation will be evaluated.

“The key is physician-led governance with structured oversight,” he says. “Encourage teams to test new ideas, but require clinical review, defined safety measures and outcome tracking before broad implementation.”

Fotinos also stresses that innovation should remain grounded in evidence and individualized patient care. Healthcare organizations often face pressure to adopt emerging technologies quickly, but lasting improvements come from validating ideas through rigorous clinical evaluation and ensuring they genuinely improve patient outcomes.

“Innovation should always be evidence-informed and patient-centered.”

Use Technology to Create Safer Feedback Loops

According to Eugene Zabolotsky, CEO of Health Helper, healthcare leaders have more opportunities than ever to experiment safely because modern technologies allow organizations to measure results continuously and adjust quickly.

“There has never been a better time to encourage safe experimentation in healthcare,” he says.

He points to remote patient monitoring, digital biofeedback tools and health applications as examples of technologies that allow leaders to test ideas while continuously monitoring performance and safety signals.

“With remote patient monitoring, digital biofeedback tools and apps, leaders can test and measure continuously and pivot quickly when outcomes or risks change.”

Technology alone does not create a culture of innovation, however. Leaders must pair new tools with clinical oversight, predefined safety expectations and clear decision points for continuing or ending an initiative.

“Guardrails, clinical oversight and clear safety thresholds turn failure into learning opportunities without compromising patient safety,” Zabolotsky says.

As healthcare becomes increasingly data-driven, organizations that build strong measurement systems will be better equipped to distinguish productive experimentation from unnecessary risk.

Build Trust Through Patient-Centered Innovation

Anna Koskinaris, also known as Anna K, Founder of Supreme Health Solutions, says experimentation in healthcare must begin with a commitment to the person receiving care.

“Healthcare has a responsibility to minimize risk while at the same time, continuing to evolve,” she says.

She emphasizes that innovation and safety should not be treated as competing objectives. Instead, organizations can create environments where new ideas are explored through thoughtful governance, evidence-based evaluation and safeguards designed around patient needs.

“Leaders can create a culture of thoughtful experimentation through clear governance, evidence-based decision-making and safeguards that allow new ideas to be tested without compromising patient safety,” she says.

A key component of this approach is ensuring that patients remain active participants in decisions about their care.

“Building trust through transparent communication and shared decision-making creates strong partnerships, better outcomes and a healthcare system where patients feel informed, respected and safe.”

For healthcare leaders, the lesson is that responsible experimentation is not only about managing clinical risk—it is also about maintaining the trust that allows innovation to succeed. When patients understand why changes are being made and how safety is being protected, organizations can create stronger partnerships and more sustainable improvements.

Create Safe-To-Fail Environments for Controlled Learning

Asaad Hakeem of SARC MedIQ Inc., believes healthcare organizations should not view failure as the opposite of safety. Instead, leaders can create environments where teams learn from unsuccessful ideas before those ideas affect patient care.

“Create ‘safe-to-fail’ innovation environments,” he says. “Pilot new ideas in controlled settings with clear clinical oversight, predefined success metrics and rapid feedback loops.”

This approach reflects principles used in high-reliability organizations, where leaders focus on anticipating problems, learning from near misses and improving systems rather than assigning blame after failures occur. The Institute for Healthcare Improvement has promoted similar concepts through improvement science methods that encourage organizations to test changes on a small scale before wider adoption.

“This encourages learning and continuous improvement while maintaining patient safety and trust,” Hakeem adds.

For healthcare executives, the goal is not to eliminate failure entirely—a difficult if not impossible standard in complex systems. Instead, leaders can design organizations where failures happen early, safely and informatively, producing insights that lead to better care delivery.

Isolate Innovation Risk Through Smart Technology Architecture

For Mahendran Chinnaiah, Digital Healthcare Architect for a major U.S. healthcare and pharmacy services firm, safe experimentation in healthcare technology begins with designing systems that allow teams to innovate without exposing critical care environments to unnecessary risk.

“To innovate safely, leaders must adopt an ‘Open-Core Innovation’ governance model based on decoupled micro-validation zones,” he says. “Instead of experimenting inside critical, monolithic care paths, build lightweight, headless backend utilities that sit safely on top of your stable legacy infrastructure.”

This architectural approach allows organizations to test new capabilities, such as data engines, automation tools and AI-driven solutions, without creating unnecessary exposure.

“If a newly developed data engine or sorting algorithm fails, it happens silently in a backend data pipeline without ever touching a front-line clinician or a live patient.”

For healthcare executives, this means shifting the focus from preventing all failures to controlling where and how failures occur.

“We must shift our mindset from avoiding failure to automating the blast radius,” Chinnaiah says.

By building environments where technology can be tested, challenged and refined before reaching patients, healthcare leaders can create a stronger foundation for responsible innovation.

Test Healthcare Technology With Discipline, Not Shortcuts

According to Sriharsha Chavali, Enterprise Technology Leader at The Aspen Group, experimentation in healthcare technology requires a disciplined engineering mindset.

“Experimentation and safety are not opposites in healthcare technology,” he says. “The best systems are built through disciplined testing, not by taking shortcuts in production.”

What truly works, he says, is “a small blast radius, clear rollback and someone accountable for watching the results.”

Chavali also highlights the value of learning from near misses. In complex healthcare environments, moments when clinicians must override automated systems provide important information about where technology may not fully reflect real-world conditions.

“When a human override corrects automation, that is signal, not noise,” he says. “The goal is not to slow innovation, but to make sure the expensive mistakes are caught early, while the cheap ones are the only ones learned from in production.”

For healthcare leaders, the objective is not to prevent every mistake from occurring. It is to design systems where errors are detected early, lessons are captured and improvements are implemented before failures become widespread.

“Use hazard analysis as the ‘license to learn,’ not as the ‘reason to say no.’”

– Suresh Alla, Senior Principal Systems Engineer at Procept Biorobotics

SHARE IT

Use Risk Analysis as a Pathway to Innovation

For Suresh Alla, Senior Principal Systems Engineer at Procept Biorobotics, healthcare organizations should rethink the role of safety processes. Rather than treating hazard analysis and risk assessment as barriers that prevent experimentation, leaders can use them as tools that make innovation possible.

“Use hazard analysis as the ‘license to learn,’ not as the ‘reason to say no.’”

This approach shifts the organizational mindset from avoiding all uncertainty to managing uncertainty intelligently.

“The leadership message should be: We encourage experimentation when hazards are named, exposure is bounded, monitoring is active and stop rules are clear,” he says.

For executives, this means safety reviews should not exist only as final approval checkpoints. Instead, they should become part of the innovation process from the beginning, helping teams understand what can be tested, what must be protected and when an approach should be reconsidered.

“Healthcare should not become risk-seeking; it should become learning-seeking inside strong safety controls.”

Creating this type of culture requires leaders to communicate that careful experimentation is not a failure of caution—it is an extension of safety itself.

Give Innovation Teams Room to Explore Within Defined Guardrails

Rajani Kumar Sindavalam, Systems Engineering Leader at HCL America Inc., believes healthcare innovation depends on creating clear boundaries that allow teams to explore new ideas while protecting patients from unintended consequences.

“To create a culture of safe innovation, healthcare leaders must clearly define the intended use, target users and environment up front, providing R&D teams a sandbox to experiment without compromising patient safety,” he says.

Rather than measuring every early idea against operational expectations designed for mature products, leaders should create stage-gate processes that evaluate concepts based on appropriate goals for each phase of development.

“Decoupling exploratory research from clinical delivery allows organizations to establish cross-functional stage-gate reviews that evaluate early prototypes based on predefined goals rather than rigid operational metrics.”

Sindavalam also highlights the cultural importance of recognizing unsuccessful experiments as sources of institutional knowledge. When teams document what did not work, future innovators can avoid repeating the same mistakes.

“When leaders provide clear boundaries for experimentation and celebrate lessons learned from failed concepts, they build a psychologically safe environment where teams boldly push technological boundaries while keeping patient care completely insulated from risk.”

For healthcare executives, the goal is to create organizations where innovation is encouraged, but never detached from accountability. Strong governance does not limit creativity—it gives creativity a safer path forward.

“Innovation accelerates when governance is proportional to risk, transparent and predictable.”

– Harikrishnan Muthukrishnan, Principal IT Developer at BCBS Florida

SHARE IT

Match Governance Requirements to the Level of Risk

For Harikrishnan Muthukrishnan, Principal IT Developer at BCBS Florida, healthcare organizations can encourage responsible experimentation by moving away from a one-size-fits-all approach to governance and creating a tiered experimentation framework.

“Healthcare leaders should govern experiments according to their potential for harm,” he says.

By aligning governance requirements with risk, healthcare leaders can avoid creating unnecessary barriers that slow beneficial improvements while maintaining appropriate safeguards for high-impact decisions.

“A scheduling improvement and a clinical decision-support tool should not face identical approval requirements,” he says. “Low-risk ideas can move through rapid team-level testing, while experiments affecting diagnoses, medication or treatment require clinical review and stronger evidence.”

Muthukrishnan emphasizes that predictable governance is essential for building an innovation culture. When teams understand what level of review is required and why, they can plan experiments more effectively rather than avoiding new ideas because approval pathways are unclear.

“Innovation accelerates when governance is proportional to risk, transparent and predictable.”

For healthcare executives, the goal is not to reduce oversight—it is to make oversight smarter. A tiered framework allows organizations to preserve rigorous protections where consequences are highest while creating room for teams to improve everyday processes that benefit patients and clinicians.

Building a Blueprint for Safe Healthcare Innovation

• Define the boundaries where experimentation is safe. Leaders should identify what cannot fail from a patient safety perspective while giving teams freedom to test improvements within clearly defined limits.
• Make physician oversight part of innovation governance. Clinical review, measurable outcomes and evidence-based evaluation help ensure new ideas improve care rather than simply introduce change.
• Use technology to create continuous learning loops. Digital tools, remote monitoring and data analytics can allow organizations to test ideas, measure outcomes and adjust quickly when risks or results change.
• Keep patients at the center of innovation decisions. Transparent communication and shared decision-making build trust while helping organizations evaluate whether new approaches truly benefit the people they serve.
• Create safe-to-fail environments for pilots. Controlled testing environments with clear success metrics and feedback loops allow teams to learn without exposing patients to unnecessary risk.
• Design technology architectures that contain risk. Micro-validation zones, sandboxes and isolated testing environments allow healthcare teams to experiment quickly while preventing failures from affecting patient care.
• Test healthcare technology with engineering discipline. Small-scale pilots, rollback plans and human oversight help organizations identify problems before they affect large populations.
• Treat risk analysis as a tool for progress. Hazard assessments and safety reviews should enable innovation by clarifying how teams can experiment responsibly.
• Separate exploration from clinical deployment. Innovation teams need protected environments where ideas can evolve before they become part of patient-facing workflows.
• Scale governance based on risk. A tiered experimentation framework allows low-risk improvements to move faster while ensuring technologies that affect clinical decisions receive appropriate review and evidence requirements.

Turning Caution Into a Catalyst for Progress

Healthcare has never advanced by eliminating uncertainty. It has advanced because leaders, clinicians and innovators learned how to ask better questions, test new ideas and improve what came before. The challenge for today’s healthcare executives is not whether to experiment—it is how to create the conditions where experimentation can happen responsibly.

Innovation does not require healthcare to abandon its standards. It requires leaders to redesign how organizations learn. When experimentation is guided by evidence, accountability and trust, even setbacks can become stepping stones toward better care.